Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis

G. Boivin; A. Erice; D. D. Crane; D. L. Dunn; H. H. Balfour

doi:10.1128/AAC.37.2.357

Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis

G. Boivin, A. Erice, D. D. Crane, D. L. Dunn, H. H. Balfour

Laboratory Medicine and Pathology

Research output: Contribution to journal › Comment/debate › peer-review

25 Scopus citations

Abstract

We determined the acyclovir (ACV) susceptibilities of herpes simplex virus (HSV) isolates (n = 18) recovered from solid organ transplant patients after antiviral prophylaxis with ACV or ganciclovir. All isolates tested were susceptible to ACV (50% inhibitory concentration, <1 μM). A clinical review of patients with HSV disease showed that all improved with specific anti-HSV therapy, and no recurrences were reported.

Original language	English (US)
Pages (from-to)	357-359
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	37
Issue number	2
DOIs	https://doi.org/10.1128/AAC.37.2.357
State	Published - 1993

Access

10.1128/AAC.37.2.357

OpenUrl availability

Full text

Cite this

@article{2ed0159dd41d46f7bba52eb8a3cd67c3,

title = "Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis",

abstract = "We determined the acyclovir (ACV) susceptibilities of herpes simplex virus (HSV) isolates (n = 18) recovered from solid organ transplant patients after antiviral prophylaxis with ACV or ganciclovir. All isolates tested were susceptible to ACV (50% inhibitory concentration, <1 μM). A clinical review of patients with HSV disease showed that all improved with specific anti-HSV therapy, and no recurrences were reported.",

author = "G. Boivin and A. Erice and Crane, {D. D.} and Dunn, {D. L.} and Balfour, {H. H.}",

year = "1993",

doi = "10.1128/AAC.37.2.357",

language = "English (US)",

volume = "37",

pages = "357--359",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis

AU - Boivin, G.

AU - Erice, A.

AU - Crane, D. D.

AU - Dunn, D. L.

AU - Balfour, H. H.

PY - 1993

Y1 - 1993

N2 - We determined the acyclovir (ACV) susceptibilities of herpes simplex virus (HSV) isolates (n = 18) recovered from solid organ transplant patients after antiviral prophylaxis with ACV or ganciclovir. All isolates tested were susceptible to ACV (50% inhibitory concentration, <1 μM). A clinical review of patients with HSV disease showed that all improved with specific anti-HSV therapy, and no recurrences were reported.

AB - We determined the acyclovir (ACV) susceptibilities of herpes simplex virus (HSV) isolates (n = 18) recovered from solid organ transplant patients after antiviral prophylaxis with ACV or ganciclovir. All isolates tested were susceptible to ACV (50% inhibitory concentration, <1 μM). A clinical review of patients with HSV disease showed that all improved with specific anti-HSV therapy, and no recurrences were reported.

UR - http://www.scopus.com/inward/record.url?scp=0027468319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027468319&partnerID=8YFLogxK

U2 - 10.1128/AAC.37.2.357

DO - 10.1128/AAC.37.2.357

M3 - Comment/debate

C2 - 8383946

AN - SCOPUS:0027468319

SN - 0066-4804

VL - 37

SP - 357

EP - 359

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 2

ER -

Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis

Abstract

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this